Company: IPHYF
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001598599-25-000042
Chunk: 304

Company: Innate Pharma SA
Filing Date: 2025-04-30
Form: 20-F
Item: Item 19
Chunk 304
---
 2002                                                                         
  12.2*               Certification by the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                                                   

  Exhibit Number      Description of Exhibit                                                                                                                                                                               Schedule/ Form      File Number      Exhibit      File Date  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  13.1**              Certification by the Principal Executive Officer and the Principal Financial Officer pursuant to 18 U. S. C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002                                                                   
  15.1*               Consent of Deloitte & Associés                                                                                                                                                                                                                                    
  15.2*               C onsent of Price w ater house Coopers A udit                                                                                                                                                                                                                     
  97.1                E xecutive Compensation C l a wback Policy                                                                                                                                                           20-F                001-39084           97.1      04/04/24   
  101. INS*           XBRL Instance Document                                                                                                                                                                                                                                            
  101. SCH*           XBRL Taxonomy Extension Schema Document                                                                                                                                                                                                                           
  101. CAL*           XBRL Taxonomy Extension Calculation Linkbase Document                                                                                                                                                                                                             
  101. DEF*           XBRL Taxonomy Extension Definition Linkbase Document                                                                                                                                                                                                              
  101. LAB*           XBRL Taxonomy Extension Label Linkbase Document                                                                                                                                                                                                                   
  101. PRE*           XBRL Taxonomy Extension Presentation Linkbase Document                                                                                                                                                                                                            

* Filed herewith.

** Furnished herewith.

† Certain portions of this exhibit have been omitted because they are not material and would likely cause competitive harm to the registrant if disclosed

SIGNATURES

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.

Innate Pharma S. A.

By: /s/ Jonathan Dickinson

Name: Jonathan Dickinson.

Title: Chief Executive Officer

Date: April 30, 2025

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

  Consolidated Financial Statements as of and for the Years Ended December 31